AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02610400 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: rfMDA
Description: Presumptive treatment, using the medication A-L, of the inhabitants of households surrounding a passively-detected index case, without incorporating a diagnostic test step. The investigators will administer A-L with dosing as follows (mg artemether / mg lumefantrine):~(i) 5-14kg patient: 20/120mg twice (8 hours apart) on day 1, 20/120mg twice (12 hours apart) on each of days 2 and 3, then stop (ii) 15-24kg patient: 40/240mg twice (8 hours apart) on day 1, 40/240mg twice (12 hours apart) on each of days 2 and 3, then stop (iii) 25-34kg patient: 60/360mg twice (8 hours apart) on day 1, 60/360mg twice (12 hours apart) on each of days 2 and 3, then stop (iv) > 34kg patient: 80/480mg twice (8 hours apart) on day 1, 80/480mg twice (12 hours apart) on each of days 2 and 3, then stop
Study NCT02496728 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile Health Application
Description: An application on a smart phone that is designed to help individuals self-monitor health behaviors.
Study NCT02496728 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mobile Health Application
Description: An application on a smart phone that is designed to help individuals self-monitor health behaviors.
Study NCT02496728 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Environmental Cues
Description: Text messages, informational posts and reminders supporting healthy behaviors.
Study NCT02496728 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Environmental Cues
Description: Text messages, informational posts and reminders supporting healthy behaviors.
Study NCT01593657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindful Movement and Breathing program
Description: Participate Mindful Movement and Breathing program with an experienced yoga instructor. All movements can be done while in a bed (e.g. turning head, shrugging shoulders, bending knees, etc). Each session lasts approximately 15 minutes.
Study NCT01593657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire administration
Description: Collected at baseline (before surgery), before and after each YST session, and at follow-up (two days after surgery).
Study NCT01593657 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: The Observer Mobility Scale
Description: Conducted by nurse and study coordinator prior to surgery and two days after surgery to assess mobility. Will ask patient to turn, sit, stand and walk as they are able.
Study NCT01593657 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Volumetric Incentive Spirometry
Description: Conducted twice before and after each Mindful Movement and Breathing program to measure lung function. Mean of the two readings used.
Study NCT02496728 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Support
Description: Participants may interact with each other through a private Facebook group.
Study NCT02496728 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social Support
Description: Participants may interact with each other through a private Facebook group.
Study NCT02496728 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational Materials
Description: Educational materials regarding healthy behaviors.
Study NCT02496728 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Educational Materials
Description: Educational materials regarding healthy behaviors.
Study NCT01716468 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Ketogenic Diet
Description: modified ketogenic diet
Study NCT01276665 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: restrictive intraoperative fluid substitution
Description: to analyze the impact of a restrictive volume regimen using advanced balanced electrolyte solution (which is by far more restrictive than the published data) combined with noradrenaline. We include only radical cystectomy and so nearly exclude surgical bias
Study NCT01276665 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: assessment of the pelvic venous pressure
Description: A 20 G catheter will be introduced into a small collateral vein of the internal iliacal vein to monitor pelvic venous pressure
Study NCT05329181 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Integrated cognitive behavioral treatment
Description: Integrated cognitive behavioral treatment adapted specifically for homeless individuals and developed to treat substance use and depressive symptoms simultaneously
Study NCT03803852 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intraocular Lens Implantation
Description: Implantation of an intraocular lens Rayner RayOne or Hoya Nanex or Hoya Vivinex Impressinto the capsular bag using an injector, after removing of the human cristalline lens.~Implantation of the Alcon Clareon toric and Rayner RayOne EMV toric IOL on the axis according to the steep meridian of the cornea
Study NCT02706184 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E. coli Nissle suspension
Description: Patients receive E. coli Nissle suspension
Study NCT02706184 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT02530359 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pirfenidone extended release
Description: Pirfenidone extended release 600mg per mouth
Study NCT01933191 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic treadmill exercise
Description: Experimental training: Aerobic treadmill exercise (30 minutes, 70% VO2max) prior to an elective minor dental procedures (e.g., extractions, endodontics, apicoectomies, dental restorations, periodontal treatment, dental implants).
Study NCT01933191 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Aerobic treadmill exercise
Description: Experimental training: Aerobic treadmill exercise (30 minutes, 70% VO2max) prior to an elective minor dental procedures (e.g., extractions, endodontics, apicoectomies, dental restorations, periodontal treatment, dental implants).
Study NCT01933191 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: placebo exercise
Description: placebo exercise: Aerobic treadmill exercise (30 minutes, 20% VO2max) prior to an elective minor dental procedures (e.g., extractions, endodontics, apicoectomies, dental restorations, periodontal treatment, dental implants).
Study NCT01933191 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo exercise
Description: placebo exercise: Aerobic treadmill exercise (30 minutes, 20% VO2max) prior to an elective minor dental procedures (e.g., extractions, endodontics, apicoectomies, dental restorations, periodontal treatment, dental implants).
Study NCT02742922 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally adapted therapy (C-MAP)
Description: C-MAP is a brief problem focused therapy, comprising of six sessions delivered within three months. C-MAP is a manual assisted intervention based on the principles of CBT .In this intervention there is an evaluation of the self-harm attempt, crisis skills, problem solving and basic cognitive techniques to manage emotions, negative thinking and relapse prevention strategies.
Study NCT03928834 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adapted Nzira Itsva
Description: Adolescents will be provided an enhanced adherence package consisting of VL testing using DBS, including the NI intervention and low-cost genotyping and drug resistance monitoring. Participants receiving the intervention will have their first session after recruitment and enrollment, and will schedule up to 4 additional booster sessions at a time convenient for them spaced approximately 1 month apart. This may be modified after the formative assessment.
Study NCT00880672 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dutasteride
Description: 5mg, oral, daily, 2-4 weeks
Study NCT01614236 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pregabalin
Description: Patients in one set (40 patients/sct) will received 150 mg of PGL or placebo at 20:00 the evening before surgery and 1.5 h before surgery and will undergo surgery under GA
Study NCT01614236 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: epidural
Description: patients will be randomized similarly but will undergo surgery under epidural analgesia
Study NCT01918098 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxycodone/naloxone prolonged release tablets
Study NCT01918098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone/naloxone prolonged release tablets
Study NCT01220648 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nilotinib, interferon-alfa
Study NCT01952834 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: GoodBelly Probiotic
Description: GoodBelly Probiotic 2.7 oz Daily x 6 weeks. Followed by a 4 week wash out period and then, Vancomycin, a non absorbed antibiotic administered (250 mg four times daily) orally for 10 days
Study NCT01952834 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vancomycin
Description: GoodBelly Probiotic 2.7 oz Daily x 6 weeks. Followed by a 4 week wash out period and then, Vancomycin, a non absorbed antibiotic administered (250 mg four times daily) orally for 10 days
Study NCT04056364 — intervention group
Intervention type: BIOLOGICAL
Intervention: sputum cytology
Description: Sputum cytology refers to the examination of sputum (mucus) under a microscope to look for abnormal or cancerous cells. Sputum, or phlegm, is the fluid that is secreted by cells in the lower respiratory tract such as the bronchi and the trachea. It differs from saliva, in that it contains cells that line the respiratory passages.
Study NCT03615638 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fall prevention program
Description: 12-week fall prevention program (including warm-up, cool-down, education, Tai Chi, and lower limb strengthening)
Study NCT02530359 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo equivalent
Description: Placebo equivalent per mouth
Study NCT02530359 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo equivalent
Description: Placebo equivalent per mouth
Study NCT04468607 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BLYG8824A
Description: BLYG8824A will be administered at a flat dose independent of body weight.
Study NCT00102544 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EM Tracking
Description: Utilizing electromagnetic tracking technology as a fusion and navigation tool for minimally invasive interventional procedures.
Study NCT02786056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lung MRI examination
Description: Lung MRI examination is performed for approximately 30 min on a 3T machine (Achieva 3T, Philips) using UTE sequences, both during free breathing with image synchronisation using an echo-navigator, and during an end-inspiratory and end-expiratory pauses. In the 10 first subjects, the MR protocol is optimized in order to maximize MRI parenchymal signal intensity, signal-to-noise ratio and contrast-to-noise ratio. The final image acquisition parameters will be applied in the following 30 subjects in order to assess the outcomes of the study.
Study NCT02423759 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ciprofloxacin
Description: 500mg ciprofloxacin twice daily starting the day before biopsy and continued for 3 days after
Study NCT02423759 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ciprofloxacin and gentamycine
Description: standard chemoprophylaxis plus gentamicin 160mg intramuscular once just before the biopsy
Study NCT02423759 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: culture based chemoprophylaxis
Description: Patients will receive antibiotic according to rectal swab culture at time of biopsy and then after for 3 days.
Study NCT03805269 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAP block
Description: TAP block: local anesthetics infiltration at trans abdominis plane
Study NCT03805269 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: wound infiltration
Description: wound infiltration: local anesthetics infiltration at surgical incision
Study NCT03756077 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 68Ga-PSMA-11 and/or 18F-FDG PET/MR, PET/CT
Description: 0.05-0.06 mCi per kilogram bodyweight of 68Ga-PSMA, 0.1-0.15 mCi per kilogram bodyweight of 18F-FDG will be injected intravenously prior to imaging
Study NCT01607242 — intervention group
Intervention type: OTHER
Intervention: Endoscopy of larynx
Description: Endoscopic Laryngeal mobility assessment
Study NCT01607242 — intervention group
Intervention type: OTHER
Intervention: Voice Handicap Index
Description: Subjective Evaluation of Voice disorders
Study NCT01607242 — intervention group
Intervention type: OTHER
Intervention: Swallowing Assesment
Description: Swallowing function questionnaire
Study NCT01785264 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-operative treatment
Description: All patients included in the study will be immobilized in equinus position for the first two weeks using a below-the-knee cast. Following the first two weeks the cast is replaced with a brace that will be used for additional six weeks during which the ankle angle will be adjusted from 3 heel-lifts to none. Patients randomized to non-operative treatment will have a cast applied within 3 days from injury.
Study NCT01785264 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open surgery
Description: All patients included in the study will be immobilized in equinus position for the first two weeks using a below-the-knee cast. Following the first two weeks the cast is replaced with a brace that will be used for additional six weeks during which the ankle angle will be adjusted from 3 heel-lifts to none.
Study NCT01785264 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mini-invasive surgery
Description: We will use the technique developed by Dr. Amlang and Professor Zwipp from Dresden, Germany. They have developed a protocol of mini-invasive surgery using specially adapted proprietary instruments.~All patients included in the study will be immobilized in equinus position for the first two weeks using a below-the-knee cast. Following the first two weeks the cast is replaced with a brace that will be used for additional six weeks during which the ankle angle will be adjusted from 3 heel-lifts to none.
Study NCT02188108 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wisconsin Stone-QOL survey
Description: Patients will complete a health-related quality of life survey at multiple time points at enrollment and at multiple time points thereafter.
Study NCT03844880 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional Awareness and Expression Therapy
Description: Focus on emotions, writing about stress, assertiveness training, role playing new ways to handle relationships, and sharing feelings and experiences with others.
Study NCT03844880 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavior Therapy
Description: Focus on cognitive and behavioral skills, such as relaxation, increasing pleasant activities, pacing, and changing ways of thinking.
Study NCT03659500 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Four-week routine bloodwork
Description: Routine hemodialysis bloodwork done every 4 weeks
Study NCT03659500 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Six-week routine bloodwork
Description: Routine hemodialysis bloodwork done every 6 weeks
Study NCT01890369 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 15g Mixed Essential Amino Acids
Description: Dissolved in 250ml water.
Study NCT04346888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HBM9161 Injection (680mg and 340 mg)
Description: HBM9161 Injection (680mg and 340mg)
Study NCT04346888 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: Placebo, HBM9161 Injection (340mg)
Study NCT01890369 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 3g Leucine
Description: Dissolved in 250ml water.
Study NCT01890369 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 15g Mixed Essential Amino Acid REFEED
Description: Dissolved in 250ml water.
Study NCT01581580 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Medtronic Activa Tremor Control System
Description: Medtronic DBS Therapy delivers electrical stimulation to an area in the brain to help treat Parkinson's Disease, dystonia, and essential tremor.
Study NCT01823978 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BPX-201 vaccine plus AP1903
Description: The trial design consists of 3 cohorts of 6 patients each, receiving escalating doses of BPX-201 of 10 million (M), 20M and 40M cells, respectively. Dose escalation will occur according to a 3+3 design. Patients will receive administration of BPX-201 every other week for 6 cycles (1 cycle equals 2 weeks). Approximately 1.6 mL of BPX-201 will be administered as 8 intradermal injections (200μL each) at each treatment visit. On the day following each vaccination, a single 40 mg dose of the activating agent, AP1903, will be administered via intravenous (IV) infusion over 2 hours.
Study NCT05164185 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Remote ischemic conditioning
Description: Brief cycles of ischemia to a limb. A blood pressure cuff was placed around the right thigh and inflated to 200 mmHg for 4 cycles of 5 minutes.
Study NCT01581580 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Deep Brain Stimulation
Description: standard of care DBS surgery for patients with Parkinson's Disease, dystonia, and essential tremor
Study NCT05164185 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Remote ischemic conditioning
Description: Brief cycles of ischemia to a limb. A blood pressure cuff was placed around the right thigh and inflated to 200 mmHg for 4 cycles of 5 minutes.
Study NCT03883711 — intervention group
Intervention type: OTHER
Intervention: Database
Description: Create a database containing clinical characteristic, clinical presentation, flow indexes and treatment of consecutive incident patients with ACS or myocardial injury.
Study NCT04118764 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuronavigation-guided single-element focused ultrasound transducer
Description: Non-invasive focused ultrasound-induced blood-brain barrier opening will be attempted using a single-element transducer, guided with a neuronavigation system.
Study NCT01778972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Otago home exercise programme
Description: Otago home exercise program was designed specifically to prevent falls. It consists of a set of leg muscle strengthening and balance retraining exercises progressing in difficulty, and a walking plan.~The exercise are individually prescribed and increase in difficulty during a series of five home visits by a physiotherapist.
Study NCT01778972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motivational interviewing plus Otago
Description: This group is not only exercising at home but also getting motivational interviewing from the physiotherapist at he five home visits. The physiotherapists doing motivational interviewing are specially trained in motivational interviewing.
Study NCT04118764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Definity
Description: Definity microbubbles (10 μl/kg) will be used in conjunction with the ultrasound transducer to temporarily open the blood brain barrier.
Study NCT04118764 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents
Description: MRI scans will be completed at baseline and immediately after the focused ultrasound treatment to confirm BBB opening and safety. A follow-up MRI will be performed three days after treatment to confirm BBB closure, only in the case of successful BBB opening.
Study NCT04118764 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography (PET)
Description: A follow-up PET scan will be performed three days after treatment to determine amyloid plaque load.
Study NCT03338010 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2963016
Description: Administered SC
Study NCT03338010 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lantus®
Description: Administered SC
Study NCT01176383 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Respiragene test and risk score
Description: This 12 gene test used with other data (family history, age and spirometry result) to calculate lifetime risk of lung cancer in smokers who do not quit smoking. This intervention is expected to be a motivator to quit.
Study NCT04118764 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Amyvid
Description: To be used during the PET scan to determine uptake of Amyvid within the treated area.
Study NCT03404713 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pathways to Health
Description: Manualized sessions will follow an acceptance based behavioral weight loss treatment approach, including guided goal-setting and self-monitoring, identifying barriers and solutions, contingency management, stimulus control, dealing with setbacks and relapse prevention. Daily food and physical activity are logged and monitored. Parents learn strategies to support and facilitate their child's weight management via family-based change.